BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2020
View Archived Issues
Soluble VEGFR-1 is a diagnostic marker of bladder pain syndrome/interstitial cystitis
Read More
VSY Biotechnology developing TR-C 19 to treat COVID-19
Read More
Small-molecule amplifiers co-translationally increase CFTR mRNA stability through PCBP1 binding
Read More
Results from a multicenter phase IIa study of PF-06700841 in patients with plaque psoriasis
Read More
Identification of a novel series of 1,6-naphthyridinone-based class II MET kinase inhibitors
Read More
CureVac announces positive preclinical data for its coronavirus vaccine candidate
Read More
FDA approves Pomalyst for AIDS-related and HIV-negative Kaposi sarcoma
Read More
FDA clears IND for LB-1148 in COVID-19-associated pulmonary dysfunction
Read More
NantKwest and ImmunityBio to begin phase II study of combination immunotherapy
Read More
Phase IIb study of PTI-125 in Alzheimer's disease does not meet primary endpoint
Read More
Genenta presents phase I/II data for Temferon cell-based therapy in patients with GBM
Read More
First-in-human data for novel proliposomal paclitaxel, TSD-001, in NMIBC
Read More
Interim phase II data for apalutamide plus abiraterone acetate/prednisone in prostate cancer
Read More
Microbiome modulates effects of ALS mutation
Read More
Designer proteins for RSV vaccine
Read More
TNFAIP2 identified as potential therapeutic target in platinum-resistant urothelial carcinoma
Read More
Medshine Discovery discloses Wee1 inhibitors
Read More
Gilead Sciences divulges PD-1/PD-L1 interaction inhibitors
Read More
Intra-Cellular Therapies patents PDE2A inhibitors
Read More
FronThera US Pharmaceuticals synthesizes new TYK2 inhibitors
Read More
Novartis divulges NLRP3 inhibitors
Read More
Otoferlin gene therapy restores hearing in congenital deafness model
Read More
CCX-140 shows no meaningful reduction in proteinuria in phase II study in FSGS
Read More
Opdivo + Yervoy approved in U.S. for first-line metastatic NSCLC with PD-L1 expression >= 1%
Read More
FDA grants accelerated approval to Rubraca for BRCA-mutated metastatic CRPC
Read More
HPTN 083 interim analysis shows LA cabotegravir highly effective at preventing HIV
Read More
FDA approves Qinlock for fourth-line treatment of advanced GIST
Read More